BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1398312)

  • 1. [Psychosocial characteristics of phenylketonuric women: birth defect prevention].
    Shiloh S; Amitay M; Aizin N; Normand M; Elitzur A; Hadar R; Cohen BE
    Harefuah; 1992 Apr; 122(8):487-92, 552. PubMed ID: 1398312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nutrition in pregnancy with phenylketonuria and birth defects.
    Matalon KM; Acosta PB; Azen C
    Pediatrics; 2003 Dec; 112(6 Pt 2):1534-6. PubMed ID: 14654660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal phenylketonuria: a metabolic teratogen.
    Levy HL; Ghavami M
    Teratology; 1996 Mar; 53(3):176-84. PubMed ID: 8761885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal phenylketonuria: an international study.
    Koch R; Hanley W; Levy H; Matalon R; Rouse B; Trefz F; Guttler F; Azen C; Friedman E; Platt L; de la Cruz F
    Mol Genet Metab; 2000; 71(1-2):233-9. PubMed ID: 11001815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The maternal phenylketonuria syndrom--still current problem].
    Didycz B; Domagała L; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Embryofetopathy of the newborn infant of a phenylketonuric mother. A diagnosis not to be missed].
    Farriaux JP; Dhondt JL; Largillière C; Lacombe A; Valat S; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):49-52. PubMed ID: 8463567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Embryonic pathology caused by maternal phenylketonuria. A cause of underdiagnosed mental retardation. A report of 8 cases].
    Campistol Plana J; Arellano Pedrola M; Poo Argüelles P; Escofet Sotera C; Pérez Olarte P; Vilaseca Buscà MA
    An Esp Pediatr; 1999 Aug; 51(2):139-42. PubMed ID: 10495499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal phenylketonuria. Review with emphasis on pathogenesis.
    Levy HL
    Enzyme; 1987; 38(1-4):312-20. PubMed ID: 3326736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal phenylketonuria: case management as a preventive approach to a chronic condition affecting pregnancy.
    Hickey CA; Covington C
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1990; 1(2):214-25. PubMed ID: 2390405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hawaii's healthy start home visiting program: determinants and impact of rapid repeat birth.
    El-Kamary SS; Higman SM; Fuddy L; McFarlane E; Sia C; Duggan AK
    Pediatrics; 2004 Sep; 114(3):e317-26. PubMed ID: 15342892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phenylketonuria: a children's disease in adulthood].
    de Valk HW; de Sonneville LM; Duran M; Poll-The BT; Erkelens DW
    Ned Tijdschr Geneeskd; 2000 Jan; 144(1):11-5. PubMed ID: 10665298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of phenylketonuric and nonphenylketonuric sibs from untreated pregnancies in a mother with phenylketonuria.
    Levy HL; Lobbregt D; Sansaricq C; Snyderman SE
    Am J Med Genet; 1992 Nov; 44(4):439-42. PubMed ID: 1442884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women with phenylketonuria: successful management of pregnancy and implications.
    Bush RT; Dukes PC
    N Z Med J; 1985 Mar; 98(775):181-3. PubMed ID: 3856760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to dietary control among pregnant women with phenylketonuria--United States, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(6):117-20. PubMed ID: 11898925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenylketonuria--change in therapeutic strategies. Study of intellectual development and dietary compliance of young phenylketonuria patients].
    Weglage J; Fünders B; von Teeffelen-Heithoff A; Ullrich K
    Fortschr Med; 1993 Nov; 111(31):485-8. PubMed ID: 8276335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of fetal damage through dietary control of maternal hyperphenylalaninemia.
    Ghavami M; Levy HL; Erbe RW
    Clin Obstet Gynecol; 1986 Sep; 29(3):580-5. PubMed ID: 3757336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research design, organization, and sample characteristics of the Maternal PKU Collaborative Study.
    Koch R; Azen C; Friedman E; Hanley W; Levy H; Matalon R; Rouse B; Trefz F; Ning J; de la Cruz F
    Pediatrics; 2003 Dec; 112(6 Pt 2):1519-22. PubMed ID: 14654657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial factors in maternal phenylketonuria: prevention of unplanned pregnancies.
    Waisbren SE; Shiloh S; St James P; Levy HL
    Am J Public Health; 1991 Mar; 81(3):299-304. PubMed ID: 1994738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perception of reproductive risk factors].
    Salinas-Martinez AM; Martínez-Sanchez C; Pérez-Segura J
    Ginecol Obstet Mex; 1993 Jan; 61():8-14. PubMed ID: 8454222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.